Pharming (PHAR) Cash from Financing Activities (2020 - 2022)
Historic Cash from Financing Activities for Pharming (PHAR) over the last 5 years, with Q2 2023 value amounting to -$5.3 million.
- Pharming's Cash from Financing Activities fell 106607.54% to -$5.3 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$5.3 million, marking a year-over-year increase of 3849.12%. This contributed to the annual value of -$2.4 million for FY2021, which is 10392.18% down from last year.
- According to the latest figures from Q2 2023, Pharming's Cash from Financing Activities is -$5.3 million, which was down 106607.54% from -$2.9 million recorded in Q4 2022.
- Over the past 5 years, Pharming's Cash from Financing Activities peaked at $3.3 million during Q3 2022, and registered a low of -$62.7 million during Q4 2019.
- Over the past 5 years, Pharming's median Cash from Financing Activities value was -$2.6 million (recorded in 2021), while the average stood at -$8.6 million.
- The largest annual percentage gain for Pharming's Cash from Financing Activities in the last 5 years was 21748.06% (2022), contrasted with its biggest fall of 12128655.46% (2022).
- Quarter analysis of 5 years shows Pharming's Cash from Financing Activities stood at -$62.7 million in 2019, then surged by 100.1% to $63326.1 in 2020, then plummeted by 3858.32% to -$2.4 million in 2021, then decreased by 21.39% to -$2.9 million in 2022, then plummeted by 82.04% to -$5.3 million in 2023.
- Its last three reported values are -$5.3 million in Q2 2023, -$2.9 million for Q4 2022, and $3.3 million during Q3 2022.